All In MedTech

Device Trial Radar · NCT04757753

Root Canal Obturation With a Ready-to-use Root Canal Sealer (PA1704) Versus BioRoot™ RCS: a Randomized Controlled Trial

Evaluation of the Efficacy Rate of Endodontic Treatment at 2 Years After Root Canal Filling With a Ready-to-use Root Canal Sealer PA1704 Versus BioRoot™ RCS: a Randomized Controlled Trial

Last checked: Nov 20, 2026Latest source record: Jun 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registryPivotal-lookingRandomized with 160 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

160

Actual

Start

Nov 6, 2020

Primary completion

Aug 29, 2023

Study completion Dec 2026

Sponsor

Lead sponsor
SeptodontNot on our public-company list
Sponsor type
Industry
Collaborators
Slb Pharma
First posted
Feb 17, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study design is a multicentric randomized controlled non-inferiority trial. 160 subjects (teeth) requiring a primary or a secondary root canal treatment will be enrolled in 2 groups (80 in each group). The aim of the study is to assess the efficacy rate and the safety 2 years after root canal obturation undertaken using a ready-to-use calcium silicate sealer (PA1704) compared to the control calcium silicate sealer BioRoot™ RCS. Procedures of root canal treatment will be conventional and standardized for all investigational centers. The canals will be cleaned, shaped and then obturated using a calcium silicate sealer (the ready to use sealer PA1704 or BioRoot™ RCS) with a single cone technique or cold lateral condensation of gutta-percha. Follow-up assessments will be conducted at 6, 12 and 24 months in both groups. The performance and safety of the sealer PA1704 will also be evaluated at 3.5 and 5 years after surgery. Retroalveolar radiographs will be taken at each study visit. The preoperative, postoperative and follow-up clinical and radiographic data will be analyzed.

Conditions

  • Root Canal Obturation

Interventions

  • ready-to-use root canal sealer: PA1704Device

    The participant will be treated with the ready-to-use root canal sealer (PA1704) in combination with gutta percha.

  • root canal sealer: BioRoot™ RCSDevice

    The participant will be treated with BioRoot™ RCS sealer in combination with gutta percha.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy Rate of Root Canal ObturationTime frame: 24 months post-treatment

Locations

5 sites in 2 countries. Site status is shown where the registry gives one.

  • Cliniques Universitaires Saint-Luc, Département de Médecine Dentaire et de Stomatologie

    Brussels, Belgium

  • Centre de santé dentaire Flandre

    Paris, France

  • Cabinet dentaire

    Rennes, France

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.